You are here: Industry Insights > Cell therapies

News List

Malaysian Genomics Pivots to Biopharmaceuticals for Growth PharmaSources
March 07, 2023
Group reports lower revenue for 2Q on switch to immunotherapy and cell therapies from vaccines
EdiGene and Neukio enter collaboration to develop next-generation immune cell therapies ExpressPharma
February 14, 2022
EdiGene, Inc and Neukio Biotherapeutics have announced an R&D collaboration to develop next-generation immune cell therapies, Neukio Biotherapeutics informed via a statement.
Twist Bioscience, Artisan Development Labs partner to discover cell therapies pharmaceutical-business-review.
January 26, 2022
Twist Bioscience has teamed up with Artisan Development Labs to discover new antibodies against five undisclosed targets.
CARsgen Therapeutics Appoints President of U.S. Ops contractpharma
January 17, 2022
Richard Daly brings 30 years of pharmaceutical industry experience, including leadership positions in multi-national corporations and biotech companies.
SQZ Biotechnologies Strengthens Board with Global Commercial and Clinical Development Experience firstwordpharma
July 02, 2021
SQZ Biotechnologies today announced the appointments of Bernard Coulie, M.D., Ph.D., and Patrick Vink, M.D., to its board of directors, adding global commercial and clinical development expertise.
Kite and Shoreline Biosciences enter partnership to develop novel allogeneic cell therapies expresspharma
June 18, 2021
Kite, a Gilead Company and Shoreline Biosciences announced a strategic partnership to develop novel cell therapies across a variety of cancer targets.
Fujifilm Cellular Dynamics and Lonza Enter Cell Therapy Partnership contractpharma
November 17, 2020
Fujifilm Cellular Dynamics, a global developer and manufacturer of human induced pluripotent stem cells (iPSC) technologies, and Lonza Walkersville, Inc., a leading global GMP iPSC manufacturer, have entered into a partnership.
Orgenesis to Collaborate with Educell to Conduct Clinical Validation of Cell Therapies Using Orgenesis’ Proprietary POCare Technologies for the Generation and Expansion of T-Cells PharmaSources.com
August 12, 2020
GERMANTOWN, MD – July 14, 2020 – Orgenesis Inc. (NASDAQ: ORGS) (“Orgenesis” or the “Company”), a pioneering global biotech company committed to accelerating commercialization and transforming the delivery of cell and gene therapies (CGTs).
Innovent Biologics enters drug development deal with Roche pharmaceutical-technology
June 10, 2020
Chinese biopharmaceutical firm Innovent Biologics has entered a strategic research and development partnership with Roche for various cell therapies and bispecific antibodies.
panCELLa, CCRM Collaborate to Benefit Academia and Industry contractpharma
April 22, 2020
New iPSC master cell banks to accelerate development of novel cell therapies.

Previous page 1 2 3 Next page